Potent kainate receptor antagonist (apparent Kd
= 5.94 μ
M). Displays ~ 30-fold selectivity over AMPA receptors.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists.
More et al.
The citations listed below are publications that use Tocris products. Selected citations for UBP 301 include:
Showing Results 1 - 1 of 1